Inventor profile of:

Pascal Deschatelets

City:

West Newton, Massachusetts

Country:

United States

Published Applications:

23

Last publication date:

2026-03-12

Top Assignees for applications by Pascal Deschatelets

The entities that hold a legal rights for patent applications filed by inventor Deschatelets Pascal:

Recent patent applications by Deschatelets Pascal

Pascal Deschatelets from West Newton, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-03-12
US20260069653A1
Human necessities

COMPLEMENT INHIBITOR DOSING REGIMENS

#2 | 2026-03-05
US20260062448A1
Chemistry; metallurgy

CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND USES THEREOF

#3 | 2025-09-11
US20250282823A1
Chemistry; metallurgy

CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND RELATED COMPOSITIONS AND METHODS

#4 | 2025-05-29
US20250170210A1
Human necessities

DOSING REGIMENS AND RELATED COMPOSITIONS AND METHODS

#5 | 2025-05-29
US20250170209A1
Human necessities

DOSING REGIMENS AND RELATED COMPOSITIONS AND METHODS

#6 | 2025-01-02
US20250000936A1
Human necessities

TREATMENT OF GEOGRAPHIC ATROPHY

#7 | 2024-08-29
US20240285783A1
Human necessities

DOSING REGIMENS AND RELATED COMPOSITIONS AND METHODS

#8 | 2024-08-29
US20240285725A1
Human necessities

DOSING REGIMENS

#9 | 2024-04-11
US20240115655A1
Human necessities

Dosing regimens and related compositions and methods

#10 | 2024-04-04
US20240110182A1
Chemistry; metallurgy

GENOMIC EDITING OF COMPLEMENT

#11 | 2024-03-07
US20240076317A1
Chemistry; metallurgy

CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND USES THEREOF

#12 | 2023-03-23
US20230091471A1
Chemistry; metallurgy

CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND RELATED COMPOSITIONS AND METHODS

#13 | 2023-03-09
US20230076527A1
Human necessities

TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

#14 | 2023-03-09
US20230075121A1
Chemistry; metallurgy

CELL-PENETRATING COMPSTATIN ANALOGS AND USES THEREOF

#15 | 2022-09-08
US20220280598A1
Human necessities

COMPLEMENT INHIBITOR DOSING REGIMENS

#16 | 2022-03-24
US20220088131A1
Human necessities

COMPOSITIONS AND METHODS RELATING TO C5L2

#17 | 2022-02-10
US20220040254A1
Human necessities

Methods of treating chronic disorders with complement inhibitors

#18 | 2021-12-30
US20210401997A1
Human necessities

Dosing regimens and related compositions and methods

#19 | 2021-09-23
US20210292368A1
Chemistry; metallurgy

Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof

#20 | 2021-07-01
US20210198320A1
Chemistry; metallurgy

Cell-penetrating compstatin analogs and uses thereof

#21 | 2021-04-15
US20210107944A1
Chemistry; metallurgy

COMPSTATIN ANALOGS FOR TREATMENT OF NEUROPATHIC PAIN

#22 | 2021-02-04
US20210032289A1
Chemistry; metallurgy

Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods

#23 | 2020-10-08
US20200316163A1
Human necessities

DOSING REGIMENS AND RELATED COMPOSITIONS AND METHODS

InventorID:

2870523 ⎘